United States · Who invested in Inozyme Pharma?
Inozyme Pharma's investors include Sanofi Ventures, New Enterprise Associates, Novo Holdings, Sofinnova Investments and Longitude Capital, and 6 more on record.
20182019
$49MSeries A$67MSeries AUnited States · Series A startup
Who invested in Inozyme Pharma
2 rounds we have observed, with the 11 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$116Mraised across 2 rounds since 2017, from 2 sources
$49MSeries A$67MSeries A
- Latest round
- Series A, $67MApr 2019
- Step-upi
- 1.4×
- Investors
- 11
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series A, $49M Nov 2017
- Biggest round
- $67M Series A · Apr 2019
- Between rounds
- 17 months from the last two
The rounds
- Apr 2019Series A$67M8 new1 returning
New Enterprise Associates
Novo Holdings
Sofinnova Investments
Longitude Capital
Sanofi Ventures
Cowen Group
Pivotal bioVenture Partners- Rock Springs
- participation RA
Reported by FinSMEsSEC filing: $34M sold, first sale Nov 2018
- Nov 2017
Founders and team
From the SEC filings it signed: 1 on the team.
- Axel BolteExecutive Officer, Directori
On the board, as filediDouglas TrecoEdward MathersLynne SullivanMartin EdwardsReinaldo DiazRob HopfnerSarah Bhagat
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Series A2017Series A2019Sanofi VenturesNew Enterprise AssociatesNovo HoldingsSofinnova InvestmentsLongitude CapitalCowen GroupPivotal bioVenture PartnersLongitude Capital/ NEANovoparticipation RA
Sanofi VenturesNew Enterprise AssociatesNovo HoldingsSofinnova InvestmentsLongitude CapitalCowen GroupPivotal bioVenture PartnersLongitude Capital/ NEANovoparticipation RAEveryone who backed them
Longitude Capital/ NEAno record of our own yet1round
Novono record of our own yet1round
participation RAno record of our own yet1round
Rock Springsno record of our own yet1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Inozyme Pharma
How much has Inozyme Pharma raised?
Inozyme Pharma has raised $116M across 2 rounds since 2017.
When did Inozyme Pharma last raise?
Inozyme Pharma's most recent round was a Series A of $67M in Apr 2019.
What was Inozyme Pharma's biggest round?
Its most recent round, $67M in Apr 2019, is also its largest on record.
Who backed Inozyme Pharma first?
Inozyme Pharma's first round on record, in Nov 2017, was backed by Sanofi Ventures, Longitude Capital/ NEA and Novo.
What stage is Inozyme Pharma at?
Inozyme Pharma's latest named round is a Series A, in Apr 2019.
Where is Inozyme Pharma based?
Inozyme Pharma is based in the United States.
Companies like Inozyme Pharma
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.